Abstract
The scalp distribution of the quantitative EEG effects of neuroactive compounds was studied in a number of pharmaco-EEG investigations, in which comparable procedures for EEG recording and processing were applied: power spectral and amplitude analyses were combined in all studies. Topographic differentiations were observed. These could include intrahemispheric and/or interhemispheric dissimilarities in the distribution of EEG effects common to the explored electrode derivations, as well as drug effects detectable only in distinct areas. The distribution could vary depending upon the EEG parameter considered; it was restricted to drug-related EEG modifications in all cases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
